Li Shiyi, Zhu Pei, Chen Fangyuan, Yu Wenqian, Xie Linjun, Xia Jing, Jiao Peng, Cui Ping, Zhang Chi, Bai Ye, Jiang Guoheng, Li Hongyu, Lou Yanmei, Li Guangcan, Shan Xuefeng, Wang Xin
West China School of Public Health Sichuan University, South Renmin Road, Wuhou District, Chengdu 610041, China.
Department of Vaccine Clinical Research Institute Mianyang City Center for Disease Control and Prevention, Mianyang, Sichuan Province, China.
Gastroenterol Res Pract. 2024 Aug 24;2024:9097892. doi: 10.1155/2024/9097892. eCollection 2024.
We aim to examine the association between liver function-related indicators and gallstone disease (GSD) risk. The subjects who participated in the China Multicenter Physical Examination Cohort (CMPEC) were enrolled. Relative odds ratios (ORs) with 95% CIs and standardized mean differences (SMDs) were applied to investigate the effect of liver function-related indicators and GSD risk. Moreover, a systematic review and meta-analysis were conducted until July 2021. Additionally, the results in the CMPEC and the systematic review and meta-analysis were combined by meta-analysis. Finally, the results were validated by a cohort study of the UK Biobank (UKB). Totally, 369,931 subjects in CMPEC were included in the study. A total of 28 publications were incorporated into the systematic review and meta-analysis. The pooled analysis suggested that aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), total protein (TP), and low albumin (ALB) were positively associated with the risk of GSD. Meanwhile, GSD present to have higher AST, ALT, gamma-glutamyl transferase (GGT), total bilirubin (TBil), globulin (G), and ALP levels and relatively lower TP and ALB levels than the healthy participants. These results were consistent when stratified by the study design, geographic background, and study quality. Only the association between ALP and GSD risk was validated in the UKB cohort. This study suggests liver function indicators were associated with GSD risk. The results may provide the basis for exploring the etiology of GSD and may help clinicians identify high-risk subjects. PROSPERO (CRD42020179076).
我们旨在研究肝功能相关指标与胆结石疾病(GSD)风险之间的关联。纳入了参加中国多中心体检队列(CMPEC)的受试者。应用相对比值比(OR)及95%置信区间(CI)和标准化均值差(SMD)来研究肝功能相关指标与GSD风险之间的关系。此外,截至2021年7月进行了一项系统评价和荟萃分析。另外,通过荟萃分析将CMPEC中的结果与系统评价和荟萃分析的结果进行合并。最后,通过英国生物银行(UKB)的队列研究对结果进行验证。本研究共纳入CMPEC中的369,931名受试者。共有28篇出版物纳入系统评价和荟萃分析。汇总分析表明,天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、碱性磷酸酶(ALP)、总蛋白(TP)和低白蛋白(ALB)与GSD风险呈正相关。同时,与健康参与者相比,GSD患者的AST、ALT、γ-谷氨酰转移酶(GGT)、总胆红素(TBil)、球蛋白(G)和ALP水平较高,而TP和ALB水平相对较低。按研究设计、地理背景和研究质量分层时,这些结果是一致的。仅在UKB队列中验证了ALP与GSD风险之间的关联。本研究表明肝功能指标与GSD风险相关。这些结果可能为探索GSD的病因提供依据,并可能有助于临床医生识别高危受试者。国际前瞻性系统评价注册库(PROSPERO)(注册号:CRD42020179076)。